title: Intracellular CMTM2 negatively regulates human immunodeficiency virus type-1 transcription through targeting the transcription factors AP-1 and CREB.
authors.affiliation: Department of Microbiology, Peking University Health Science Center, Beijing 100191, China.
authors.forename: Hong-shuo
authors.initials: HS
authors.lastname: Song
authors.forename: Shuang
authors.initials: S
authors.lastname: Shi
authors.forename: Xiao-zhi
authors.initials: XZ
authors.lastname: Lu
authors.forename: Feng
authors.initials: F
authors.lastname: Gao
authors.forename: Ling
authors.initials: L
authors.lastname: Yan
authors.forename: Ying
authors.initials: Y
authors.lastname: Wang
authors.forename: Hui
authors.initials: H
authors.lastname: Zhuang
mesh_terms: D018925:Chemokines / Q000502:physiology*; D017362:Cyclic AMP Response Element-Binding Protein / Q000037:antagonists & inhibitors*; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D042541:Intracellular Space / Q000378:metabolism; D019169:Jurkat Cells; D062792:MARVEL Domain-Containing Proteins; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D018808:Transcription Factor AP-1 / Q000037:antagonists & inhibitors*; D014158:Transcription, Genetic; D020298:U937 Cells
chemical_list: C505071:CMTM2 protein, human; C115163:CREB1 protein, human; D018925:Chemokines; D017362:Cyclic AMP Response Element-Binding Protein; D062792:MARVEL Domain-Containing Proteins; D018808:Transcription Factor AP-1; D013755:Tetradecanoylphorbol Acetate